Kimoto M
Department of Immunology, Saga Medical School, Nabeshima, 849, Japan
Methods. 1996 Jun;9(3):430-8. doi: 10.1006/meth.1996.0049.
The recognition of antigen by T lymphocytes (T cells) is restricted by Class I or Class II major histocompatibility complex (MHC) gene products, the phenomenon called "MHC restriction." MHC restriction is speculated to be one of the major elements for the association of disease susceptibility to MHC haplotypes. Clones of T cells have been shown to be powerful tools for the analysis of such restriction specificity. In this report, I describe unique mixed-isotype Abetad/Ealphad restriction molecules detected by T-cell clones in (B6Ealphad x BALB/c)F1 transgenic mice. The restriction specificity of these clones was confirmed by anti-Class II mAb blocking experiments. The ability of spleen cells from Abetad and Ealphad double transgenic B6 (B6AbetadEalphad) mice that express Abetad/Ealphad molecules to present KLH to these clones supported the existence of such unique specificity. I also describe autoreactive as well as KLH-reactive T-cell clones restricted by mixed-haplotype Abetaz/Aalphad Class II molecules derived from (NZB x NZW)F1 (B/WF1) mice. The restriction specificity was demonstrated by mAb blocking experiments and by experiments using Class II gene-transfected antigen-presenting cells. It is possible that such unique mixed-isotype and mixed-haplotype Class II molecules are critically involved in autoimmunity. In addition, the detailed methodology for establishing T-cell clones currently employed in my laboratory is described.
T淋巴细胞(T细胞)对抗原的识别受I类或II类主要组织相容性复合体(MHC)基因产物的限制,这一现象称为“MHC限制”。据推测,MHC限制是疾病易感性与MHC单倍型关联的主要因素之一。T细胞克隆已被证明是分析这种限制特异性的有力工具。在本报告中,我描述了在(B6Eαd x BALB/c)F1转基因小鼠中通过T细胞克隆检测到的独特的混合同种型Abeta d/Ealpha d限制分子。这些克隆的限制特异性通过抗II类单克隆抗体阻断实验得到证实。表达Abeta d/Ealpha d分子的Abeta d和Ealpha d双转基因B6(B6Abeta dEalpha d)小鼠的脾细胞向这些克隆呈递钥孔血蓝蛋白(KLH)的能力支持了这种独特特异性的存在。我还描述了受源自(NZB x NZW)F1(B/WF1)小鼠的混合单倍型Abeta z/Aalpha d II类分子限制的自身反应性以及KLH反应性T细胞克隆。通过单克隆抗体阻断实验以及使用II类基因转染的抗原呈递细胞的实验证明了这种限制特异性。这种独特的混合同种型和混合单倍型II类分子可能在自身免疫中起关键作用。此外,还描述了我实验室目前用于建立T细胞克隆的详细方法。